Therefore, we examined whether the use of high‐dose corticosteroids after first administration of PD‐1/PD‐L1 immune checkpoint inhibitors was associated with an increased rate of hospitalization for infection among renal, urothelial, and lung cancer patients treated with PD‐1/PD‐L1 immune checkpoint inhibitors. This evidence concerns the gene PDCD1 and infection.